Background/Aims: Accumulating evidence from a relatively small number of prospective studies indicates that exposure to prenatal stress profoundly influences the developing human fetus with consequences that persist into childhood and very likely forever. Methods: Maternal/fetal dyads are assessed at ∼20, ∼25, ∼31 and ∼36 weeks of gestation. Infant assessments begin 24 h after delivery with the collection of cortisol and behavioral responses to the painful stress of the heel-stick procedure and measures of neonatal neuromuscular maturity. Infant cognitive, neuromotor development, stress and emotional regulation are evaluated at 3, 6 12 and 24 months of age. Maternal psychosocial stress and demographic information is collected in parallel with infant assessments. Child neurodevelopment is assessed with cognitive tests, measures of adjustment and brain imaging between 5 and 8 years of age. Results: Psychobiological markers of stress during pregnancy, especially early in gestation, result in delayed fetal maturation, disrupted emotional regulation and impaired cognitive performance during infancy and decreased brain volume in areas associated with learning and memory in 6- to 8-year-old children. We review findings from our projects that maternal endocrine alterations that accompany pregnancy and influence fetal/infant/child development are associated with decreased affective responses to stress, altered memory function and increased risk for postpartum depression. Conclusions: Our findings indicate that the mother and her fetus both are influenced by exposure to psychosocial and biological stress. The findings that fetal and maternal programming occur in parallel may have important implications for long-term child development and mother/child interactions.

Keywords:
Prenatal stress, Pregnancy, Infant development, Anxiety, Fetal development, CRH, Sex differences, Fetal programming, Developmental origins of disease, Cortisol
1.
McLean M, et al: A placental clock controlling the length of human pregnancy. Nat Med 1995;1:460–463.
2.
Sandman CA, et al: Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin-releasing hormone: priming the placental clock. Peptides 2006;27:1457–1463.
3.
Barker DJP: Mothers, Babies and Health in Later Life. Edinburgh, Churchill Livingstone, 1998.
4.
Barker DJ, et al: The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 1993;306:422–426.
5.
McCormack VA, et al: Fetal growth and subsequent risk of breast cancer: results from long-term follow-up of Swedish cohort. BMJ 2003;326:248.
6.
Roseboom TJ, et al: Coronary heart disease after prenatal exposure to the Dutch famine 1944–45. Heart 2000;84:595–598.
7.
Richards M, et al: Birth weight and cognitive function in the British 1946 birth cohort: longitudinal population-based study. BMJ 2001;322:199–203.
8.
Cookson H, et al: Mothers’ anxiety during pregnancy is associated with asthma in their children. J Allergy Clin Immunol 2009;123:847–853, e11.
9.
Davis EP, Sandman CA: The timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development. Child Dev 2010;81:131–148.
10.
Smith R, et al: Corticotropin-releasing hormone in chimpanzee and gorilla pregnancies. J Clin Endocrinol Metab 1999;84:2820–2825.
11.
Lowry PJ: Corticotropin-releasing factor and its binding protein in human plasma. Ciba Found Symp 1993;172:108–115.
12.
Robinson BG, et al: Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988;85:5244–5248.
13.
Petraglia F, et al: Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev 1996;17:156–186.
14.
Suda T, et al: Responses to corticotropin-releasing hormone and its bound and free forms in pregnant and nonpregnant women. J Clin Endocrinol Metab 1989;69:38–42.
15.
Schulte HM, Weisner D, Allolio B: The corticotrophin-releasing hormone test in late pregnancy: lack of adrenocorticotrophin and cortisol response. Clin Endocrinol (Oxf) 1990;33:99–106.
16.
Ho JT, Lewis JG, O’Loughlin P: Reduced maternal corticosteroid-binding globulin and cortisol levels in pre-eclampsia and gamete recipient pregnancies. Clin Endocrinol (Oxf) 2007;66:869–877.
17.
King BR, Nicholson RC, Smith R: Placental corticotrophin-releasing hormone, local effects and fetomaternal endocrinology. Stress 2001;4:219–233.
18.
Kajantie E, et al: Placental 11β-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants. J Clin Endocrinol Metab 2003;88:493–500.
19.
Murphy VE, Clifton VL: Alterations in human placental 11β-hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. Placenta 2003;24:739–744.
20.
Ma XH, Wu WX, Nathanielsz PW: Gestation-related and betamethasone-induced changes in 11β-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta. Am J Obstet Gynecol 2003;188:13–21.
21.
Mairesse J, et al: Maternal stress alters endocrine function of the feto-placental unit in rats. Am J Physiol Endocrinol Metab 2007;292:E1526–E1533.
22.
De Weerth C, Buitelaar JK: Cortisol awakening response in pregnant women. Psychoneuroendocrinology 2005;30:902–907.
23.
Entringer S, et al: Attenuation of maternal psychophysiological stress responses and the maternal cortisol awakening response over the course of human pregnancy. Stress 2010;13:258–268.
24.
Glynn LM, et al: Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol 2008;27:43–51.
25.
Glynn L, et al: When stress happens matters: the effects of earthquake timing on stress responsivity in pregnancy. Am J Obstet Gynecol 2001;184:637–642.
26.
Glynn L: Implications of maternal programming for fetal neurodevelopment; in Zimmerman A, Conners S (eds): Maternal Influences on Fetal Neurodevelopment: Clinical and Research Aspects. New York, Springer, 2010, pp 33–53.
27.
Dunkel Schetter C, Glynn LM: Stress in pregnancy: empirical evidence and theoretical issues to guide interdisciplinary research; in Contrada R, Baum A (eds): Handbook of Stress. New York, Springer, 2010.
28.
Dunkel Schetter C: Stress processes in pregnancy and preterm birth. Curr Dir Psychol Sci 2009;18:204–209.
29.
Glynn LM, Sandman CA: The influence of prenatal stress and adverse birth outcomes on human cognitive and neurological development; in International Review of Research in Mental Retardation. New York, Academic Press, 2006, pp 109–129.
30.
Ferreira A: Prenatal Environment. Springfield, Thomas, 1969.
31.
McDonald RL: The role of emotional factors in obstetric complications: a review. Psychosom Med 1968;30:222–237.
32.
Benson P, et al: Foetal heart rate and maternal emotional state. Br J Med Psychol 1987;60:151–154.
33.
Talbert D, Benson P, et al: Fetal response to maternal anxiety: a factor in antepartum heart rate monitoring. J Obstet Gynecol 1982;3:34–38.
34.
Monk C, et al: Maternal stress responses and anxiety during pregnancy: effects on fetal heart rate. Dev Psychobiol 2000;36:67–77.
35.
Van den Bergh BR, et al: The effect of (induced) maternal emotions on fetal behavior: a controlled study. Early Hum Dev 1989;19:9–19.
36.
Groome L, et al: Maternal anxiety during pregnancy: effect on fetal behavior at 38–40 weeks of gestation. J Dev Behav Pediatr 1995;16:391–396.
37.
Sjöström K, et al: Maternal anxiety in late pregnancy and fetal hemodynamics. Eur J Obstet Gynecol Reprod Biol 1997;74:149–155.
38.
Zimmer EZ: Fetal vibroacoustic stimulation. Obstet Gynecol 1993;81:451–457.
39.
Field T, et al: Effects of ultrasound feedback on pregnancy anxiety, fetal activity, and neonatal outcome. Obstet Gynecol 1985;66:525–528.
40.
Sandman CA, et al: Maternal stress, HPA activity, and fetal/infant outcome. Ann N Y Acad Sci 1997;814:266–275.
41.
Sandman CA, et al: Maternal corticotropin-releasing hormone and habituation in the human fetus. Dev Psychobiol 1999;34:163–173.
42.
Sandman CA, et al: Maternal hypothalamic-pituitary-adrenal dysregulation during the third trimester influences human fetal responses. Dev Neurosci 2003;25:41–49.
43.
Class QA, et al: Low levels of corticotropin-releasing hormone during early pregnancy are associated with precocious maturation of the human fetus. Dev Neurosci 2008;30:419–426.
44.
Buss C, et al: Maturation of the human fetal startle response: evidence for sex-specific maturation of the human fetus. Early Hum Dev 2009;85:633–638.
45.
Dickerson PA, et al: Early emergence of increased fearful behavior in prenatally stressed rats. Physiol Behav 2005;86:586–593.
46.
Maccari S, Morley-Fletcher S: Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations. Psychoneuroendocrinology 2007;32:10–15.
47.
Van Den Hove DLA, Blanco CE, Aendekerk B: Prenatal restraint stress and long-term affective consequences. Dev Neurosci 2005;27:313–320.
48.
Weinstock M: Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog Neurobiol 2001;65:427–451.
49.
Schneider ML, Coe CL: Repeated social stress during pregnancy impairs neuromotor development of the primate infant. J Dev Behavior Pediatr 1993;14:81–87.
50.
Schneider ML, et al: Growth and development following prenatal stress exposure in primates: an examination of ontogenetic vulnerability. Child Dev 1999;70:263–274.
51.
Clarke AS, et al: Long-term effects of prenatal stress on HPA activity in juvenile rhesus monkeys. Dev Psychobiol 1994;27:257–269.
52.
Coe CL, et al: Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biol Psychiatry 2003;54:1025–1034.
53.
Davis EP, et al: Maternal plasma corticotropin-releasing hormone levels during pregnancy are associated with infant temperament. Dev Neurosci 2005;27:299–305.
54.
Huizink AC, et al: Psychological measures of prenatal stress as predictors of infant temperament. J Am Acad Child Adolesc Psychiatry 2002;41:1078–1085.
55.
O’Connor TG, Heron J, Glover V: Antenatal anxiety predicts child behavioral/emotional problems independently of postnatal depression. J Am Acad Child Adolesc Psychiatry 2002;41:1470–1477.
56.
Davis EP, et al: Prenatal maternal anxiety and depression predict negative behavioral reactivity in infancy. Infancy 2004;6:319–331.
57.
Bergman K, et al: Maternal stress during pregnancy predicts cognitive ability and fearfulness in infancy. J Am Acad Child Adolesc Psychiatry 2007;46:1454–1463.
58.
De Weerth C, Van Hees Y, Buitelaar J: Prenatal maternal cortisol levels and infant behavior during the first 5 months. Early Hum Dev 2003;74:139–151.
59.
Grant KA, et al: Maternal prenatal anxiety, postnatal caregiving and infants’ cortisol responses to the still-face procedure. Dev Psychobiol 2009;51:625–637.
60.
Kinsella MT, Monk C: Impact of maternal stress, depression and anxiety on fetal neurobehavioral development. Clin Obstet Gynecol 2009;52:425–440.
61.
Davis EP, et al: Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry 2007;46:737–746.
62.
Davis EP, et al: Prenatal maternal stress programs infant stress regulation. J Child Psychol Psychiatry 2011;52:119–129.
63.
Davis EP, Waffarn F, Sandman CA: Prenatal exposure to synthetic glucocorticoids impairs stress regulation among healthy full-term infants. Dev Psychobiol 2011;53:175–183.
64.
Huizink AC, et al: Stress during pregnancy is associated with developmental outcome in infancy. J Child Psychol Psychiatry 2003;44:810–818.
65.
Mennes M, et al: Long-term cognitive sequelae of antenatal maternal anxiety: involvement of the orbitofrontal cortex. Neurosci Biobehav Rev 2006;30:1078–1086.
66.
DiPietro JA, et al: Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev 2006;77:573–587.
67.
Van den Bergh B: The influence of maternal emotion during pregnancy on fetal and neonatal behavior. Pre- Peri-Nat Psychol J 1990;5:119–130.
68.
Hacking D, et al: Respiratory distress syndrome and antenatal corticosteroid treatment in premature twins. Arch Dis Child Fetal Neonatal Ed 2001;85:F77–F78.
69.
Giannopoulos G, Jackson K, Tulchinsky D: Glucocorticoid metabolism in human placenta, decidua, myometrium, and fetal membranes. J Steroid Biochem 1982;17:371–374.
70.
Murphy VE, et al: Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 2006;27:141–169.
71.
Peterson BS, et al: Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 2000;284:1939–1947.
72.
Buss C, et al: Maternal care modulates the relationship between prenatal risk and hippocampal volume in women but not in men. J Neurosci 2007;27:2592–2595.
73.
Abernethy LJ, Palaniappan M, Cooke RW: Quantitative magnetic resonance imaging of the brain in survivors of very low birth weight. Arch Dis Child 2002;87:279–283.
74.
Nosarti C, et al: Adolescents who were born very preterm have decreased brain volumes. Brain 2002;125:1616–1623.
75.
Beauchamp MH, et al: Preterm infant hippocampal volumes correlate with later working memory deficits. Brain 2008;131:2986–2994.
76.
Buss C, et al: High pregnancy anxiety during mid-gestation is associated with decreased gray matter density in 6- to 9-year-old children. Psychoneuroendocrinology 2010;35:141–153.
77.
Connolly JD, et al: Human fMRI evidence for the neural correlates of preparatory set. Nat Neurosci 2002;5:1345–1352.
78.
Squire LR, Stark CE, Clark RE: The medial temporal lobe. Annu Rev Neurosci 2004;27:279–306.
79.
Hoistad M, Barbas H: Sequence of information processing for emotions through pathways linking temporal and insular cortices with the amygdala. Neuroimage 2008;40:1016–1033.
80.
Nakamura K, Kubota K: The primate temporal pole: its putative role in object recognition and memory. Behav Brain Res 1996;77:53–77.
81.
Ahmad Z, et al: Auditory comprehension of language in young children: neural networks identified with fMRI. Neurology 2003;60:1598–1605.
82.
Mestres-Misse A, et al: Functional neuroanatomy of meaning acquisition from context. J Cogn Neurosci 2008;20:2153–2166.
83.
Kinnunen AK, Koenig JI, Bilbe G: Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal pole. J Neurochem 2003;86:736–748.
84.
Roceri M, et al: Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 2002;7:609–616.
85.
Pickering C, et al: Repeated maternal separation of male Wistar rats alters glutamate receptor expression in the hippocampus but not the prefrontal cortex. Brain Res 2006;1099:101–108.
86.
Lemaire V, et al: Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA 2000;97:11032–11037.
87.
Fujioka A, et al: Differential effects of prenatal stress on the morphological maturation of hippocampal neurons. Neuroscience 2006;141:907–915.
88.
Odagiri K, et al: Psychological prenatal stress reduced the number of BrdU immunopositive cells in the dorsal hippocampus without affecting the open field behavior of male and female rats at one month of age. Neurosci Lett 2008;446:25–29.
89.
Lemaire V, et al: Postnatal stimulation of the pups counteracts prenatal stress-induced deficits in hippocampal neurogenesis. Biol Psychiatry 2006;59:786–792.
90.
Fumagalli F, et al: Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 2004;20:1348–1354.
91.
Van den Hove DL, et al: Prenatal stress and neonatal rat brain development. Neuroscience 2006;137:145–155.
92.
Aisa B, et al: Effects of neonatal stress on markers of synaptic plasticity in the hippocampus: implications for spatial memory. Hippocampus 2009;19:1222–1231.
93.
Ehlers CL, et al: Corticotropin-releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res 1983;278:332–336.
94.
Baram TZ, et al: The CRF1 receptor mediates the excitatory actions of corticotropin-releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res 1997;770:89–95.
95.
Baram TZ, et al: Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol 1992;31:488–494.
96.
Baram TZ, Hatalski CG: Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21:471–476.
97.
Joels M, Baram TZ: The neuro-symphony of stress. Nat Rev Neurosci 2009;10:459–466.
98.
Maecker H, et al: Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Res 1997;744:166–170.
99.
Strijbos PJ, Relton JK, Rothwell NJ: Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain. Brain Res 1994;656:405–408.
100.
Baram TZ, Ribak CE: Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization. Neuroreport 1995;6:277–280.
101.
Brunson KL, et al: Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci USA 2001;98:8856–8861.
102.
Hollrigel GS, et al: The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience 1998;84:71–79.
103.
Chen Y, et al: Rapid loss of dendritic spines after stress involves derangement of spine dynamics by corticotropin-releasing hormone. J Neurosci 2008;28:2903–2911.
104.
Smith R, et al: Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998;83:2916–2920.
105.
Gitau R, et al: Fetal exposure to maternal cortisol. Lancet 1998;352:707–708.
106.
Gitau R, et al: Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. J Clin Endocrinol Metab 2001;86:104–109.
107.
Jacobson L, Sapolsky R: The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991;12:118–134.
108.
Diorio D, Viau V, Meaney MJ: The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 1993;13:3839–3847.
109.
Sanchez MM, et al: Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 2000;20:4657–4668.
110.
Noorlander CW, et al: Ontogeny of hippocampal corticosteroid receptors: effects of antenatal glucocorticoids in human and mouse. J Comp Neurol 2006;499:924–932.
111.
Zarrow MX, Philpott JE, Denenberg VH: Passage of 14C-4-corticosterone from the rat mother to the foetus and neonate. Nature 1970;226:1058–1059.
112.
Sapolsky RM, Krey LC, McEwen BS: Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985;5:1222–1227.
113.
Sapolsky RM, et al: Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990;10:2897–2902.
114.
Uno H, et al: Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 1994;28:336–348.
115.
Nitta A, et al: Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone. J Neurosci Res 1999;57:227–235.
116.
Huang WL, et al: Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci 2001;19:415–425.
117.
Coe CL, Lulbach GR, Schneider ML: Prenatal disturbance alters the size of the corpus callosum in young monkeys. Dev Psychobiol 2002;41:178–185.
118.
Kapoor A, Petropoulos S, Matthews SG: Fetal programming of hypothalamic-pituitary-adrenal axis function and behavior by synthetic glucocorticoids. Brain Res Rev 2008;57:586–595.
119.
LaPlante DP, et al: Stress during pregnancy affects general intellectual and language functioning in human toddlers. Pediatr Res 2004;56:400–410.
120.
Yehuda R, et al: Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J Clin Endocrinol Metab 2005;90:4115–4118.
121.
Rice F, et al: The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences. Psychol Med 2009;40:1–11.
122.
Bale TL: Neuroendocrine and immune influences on the CNS: it’s a matter of sex. Neuron 2009;64:13–16.
123.
Lin Y, et al: Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb Cortex 2009;19:1978–1989.
124.
Boukouvalas G, et al: High-fat feeding influences the endocrine responses of pubertal rats to an acute stress. Neuroendocrinology 2010;92:235–245.
125.
Goel N, Bale TL: Identifying early behavioral and molecular markers of future stress sensitivity. Endocrinology 2007;148:4585–4591.
126.
Mueller BR, Bale TL: Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 2008;28:9055–9065.
127.
Gabory A, Attig L, Junien C: Sexual dimorphism in environmental epigenetic programming. Mol Cell Endocrinol 2009;304:8–18.
128.
Ellman LM, et al: Timing of fetal exposure to stress hormones: effects on newborn physical and neuromuscular maturation. Dev Psychobiol 2008;50:232–241.
129.
Bernardes J, et al: Linear and complex heart rate dynamics vary with sex in relation to fetal behavioural states. Early Hum Dev 2008;84:433–439.
130.
DiPietro JA, et al: Fetal neurobehavioral development: associations with socioeconomic class and fetal sex. Dev Psychobiol 1998;33:79–91.
131.
Kesler SR, et al: Brain volume reductions within multiple cognitive systems in male preterm children at age twelve. J Pediatr 2008;152:513–520, e1.
132.
Clifton VL: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 2010;31 (suppl 1):S33–S39.
133.
Diamond MC, Johnson RE, Ingram C: Brain plasticity induced by environment and pregnancy. Int J Neurosci 1971;2:171–178.
134.
Keyser-Marcus L, et al: Alterations of medial preoptic area neurons following pregnancy and pregnancy-like steroidal treatment in the rat. Brain Res Bull 2001;55:737–745.
135.
Kinsely CH, Lambert KG: The maternal brain. Sci Am 2006;294:72–79.
136.
Kinsely CH, et al: Motherhood improves learning and memory. Nature 1999;402:137–138.
137.
Kinsely CH, et al: Motherhood and the hormones of pregnancy modify concentrations of hippocampal neuronal dendritic spines. Horm Behav 2006;49:131–142.
138.
Pawluski JL, Galea LAM: Hippocampal morphology is differentially affected by reproductive experience in the mother. J Neurobiol 2006;66:71–81.
139.
Gatewood JD, et al: Motherhood mitigates aging-related decrements in learning and memory and positively affects brain aging in the rat. Brain Res Bull 2005;66:91–98.
140.
Glynn LM, et al: Pregnancy affects appraisal of negative life events. J Psychosom Res 2004;56:47–52.
141.
De Weerth C, Buitelaar JK: Physiological stress reactivity in human pregnancy – a review. Neurosci Biobehav Rev 2005;29:295–312.
142.
Feldman R, et al: Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding. Psychol Sci 2007;18:965–970.
143.
Fleming AS, et al: Hormonal and experiential correlates of maternal responsiveness during pregnancy and the puerperium in human mothers. Horm Behav 1997;31:145–158.
144.
Fleming AS, Steiner M, Corter C: Cortisol, hedonics and maternal responsiveness. Horm Behav 1997;32:85–98.
145.
Swain JE, et al: Maternal brain response to own baby-cry is affected by cesarean section delivery. J Child Psychol Psychiatry 2008;49:1042–1052.
146.
Lederman SA, et al: The effects of the World Trade Center event on birth outcomes among term deliveries at three lower Manhattan hospitals. Environ Health Perspect 2004;112:1772–1778.
147.
Buss C, et al: The maternal cortisol awakening response in human pregnancy is associated with the length of gestation. Am J Obstet Gynecol 2010;201:e1–e8.
148.
Brindle PM, et al: Objective and subjective memory impairment in pregnancy. Psychol Med 1991;21:647–653.
149.
Poser CM, Kassirer MR, Peyser JM: Benign encephalopathy of pregnancy. Acta Neurol Scand 1986;73:39–43.
150.
Henry JD, Rendell PG: A review of the impact of pregnancy on memory function. J Clin Exp Neuropsychol 2007;29:793–803.
151.
Yim IS, et al: Prenatal β-endorphin as an early predictor of postpartum depressive symptoms in euthymic women. J Affect Disord 2010;125:128–133.
152.
Lord C, et al: Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging 2008;29:95–101.
153.
Protopopescu X, et al: Hippocampal structural changes across the menstrual cycle. Hippocampus 2008;18:985–988.
154.
Weissheimer KB, et al: Interactions of corticotropin-releasing factor, urocortin and citalopram in a primate model of stress-induced amenorrhea. Neuroendocrinology 2010;92:224–234.
155.
Oatridge A, Holdcroft A, et al: Change in brain size during and after pregnancy: study in healthy women and women with preeclampsia. Am J Neuroradiol 2002;13:19–26.
156.
Petraglia F, et al: Neuroendocrinology of the human placenta. Front Neuroendocrinol 1990;11:6–37.
157.
Denver RJ: Environmental stress as a developmental cue: corticotropin-releasing hormone is a proximate mediator of adaptive phenotypic plasticity in amphibian metamorphosis. Horm Behav 1997;31:169–179.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.